Results 141 to 150 of about 272,684 (347)

Genital Crohn's disease in pediatrics and genetic associations

open access: yesJPGN Reports, EarlyView.
Abstract Genital edema is a rare presentation of Crohn's disease (CD), also known as metastatic CD (MCD). This may precede, co‐occur with, or follow gastrointestinal symptoms and present a diagnostic challenge. We aimed to characterize the features, clinical courses, pathogenesis, and outcomes of patients with MCD to increase understanding and promote ...
Erica Chang   +5 more
wiley   +1 more source

Psoriasis [PDF]

open access: yesThe Boston Medical and Surgical Journal
n ...
openaire   +2 more sources

Ixekizumab Type I Allergy in a Patient With Psoriasis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT A 52‐year‐old Caucasian woman was referred for an allergy workup of suspected type I allergy to the interleukin (IL)‐17A inhibitor ixekizumab. Five months after ixekizumab initiation, she suddenly developed intense pruritus and three small wheals at the injection site approximately 30 min after injection, lasting up to 3 days.
Carina Borst   +2 more
wiley   +1 more source

Association between plasma odd-chain fatty acid levels and immune cell traits in psoriasis: insights from a prospective cohort study

open access: yesFrontiers in Immunology
Background/ObjectivesPsoriasis is a chronic, immune-mediated skin disease frequently linked to metabolic dysregulation. Odd-chain fatty acids (OCFAs), a group of bioactive lipids, have been implicated in inflammation and metabolic health; however, their ...
Rongcan Shi   +16 more
doaj   +1 more source

Patient's Perspective on the Impact of Psoriasis on Their Quality of Life After 1 Year of Tildrakizumab Treatment: Despite Clinical Improvement, Persistence of a Potential Mental Cicatricial Memory of the Disease

open access: yesJEADV Clinical Practice, EarlyView.
In this real‐life study, tildrakizumab confirmed its efficacy in treating moderate‐to‐severe psoriasis, including challenging areas. Despite good disease control, some patients expressed dissatisfaction, highlighting the cumulative mental burden of delayed effective treatment and underscoring the mental scars left by psoriasis, persisting even after ...
Ziad Reguiai   +16 more
wiley   +1 more source

Topical TYK2 inhibitor ameliorates psoriasis‐like dermatitis via the AKT‐SP1‐NGFR‐AP1 pathway in keratinocytes

open access: yesClinical and Translational Medicine
Introduction Tyrosine kinase 2 (TYK2)‐dependent cytokine signalling is integral to the pathogenesis of psoriasis. While BMS‐986165, a highly selective TYK2 inhibitor, has recently been approved for oral treatment of psoriasis, its therapeutic potential ...
Zhiqin Fang   +5 more
doaj   +1 more source

The Association of Psoriasis With Sleep Disorders in a Diverse National Cohort

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Higher prevalence of sleep disorders is seen in persons with psoriasis (PsO). However, the extent to which sleep conditions are linked to PsO severity, particularly across diverse populations, remains unknown. Bridging this knowledge gap is vital for developing comprehensive, equitable and personalized care strategies. Objectives We
Michael J. Diaz   +6 more
wiley   +1 more source

The progress and prospects of targeting the adenosine pathway in cancer immunotherapy

open access: yesBiomarker Research
Despite the notable success of cancer immunotherapy, its effectiveness is often limited in a significant proportion of patients, highlighting the need to explore alternative tumor immune evasion mechanisms.
Yuying Yang   +7 more
doaj   +1 more source

Role of Topical Ketoconazole in Therapeutic Hair Care Beyond Seborrhoeic Dermatitis and Dandruff

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Ketoconazole shampoo has well‐documented consistent efficacy and safety in treating dandruff and seborrhoeic dermatitis (SD) when compared to other active antidandruff ingredients such as selenium sulphide, corticosteroids and zinc pyrithione.
Aditya K. Gupta   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy